Immunomodulatory actions of Viscum album (Iscador) in children with recurrent respiratory disease as a result of the Chernobyl nuclear accident

Complementary Therapies in Medicine

Volumn 5, Issue 3, 1997, Pages 141-146

  Chernyshov, V P ^a   Omelchenko, L I ^a   Heusser, P ^b   Slukvin, I I ^a   Vodyanik, M A ^a   Galazyuk, L V ^a   Vykhovanets, E V ^a   Pochinok, T V ^a   Chernyshov, A V ^a   Gumenyuk, M E ^a   Schaefermeyer, H ^b   Schaefermeyer, G ^b  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b Lukas Clinic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SODIUM CHLORIDE; UKRAIN;

ARTICLE; CHERNOBYL ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NUCLEAR ACCIDENT; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; VISCUM ALBUM;

EID: 0030810015     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0965-2299(97)80056-8     Document Type: Article

References (19)

1. Hajto T. Immunomodulatory effects of Iscador°: a Viscum album preparation. Oncology 1986; 43 (suppl 1): 51-65.
2. Hajto T, Lanzrein C. Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum-album-treated breast cancer patients. Oncology 1986; 43: 93-97.
3. Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ. Increased secretion of tumor necrosis factor a, interleukin 1, and interleukin 6 by human mononuclear cells to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990; 50: 3322-3326.
4. Abelin T, Averkin JI, Egger M et al. Thyroid cancer in Belarus post-Chernobyl: Improved detection or increased incidence? Soz Präventivmed 1994; 39: 189-197.
5. Spizhenko JP. Results of Chernobyl accident for health of the people. In: Chernobyl i zdorovje ludej. Kiev 1993: 1.
6. Antipkin JG, Omelchenko LI, Pochinok TV, Vasjuk AN, Chernyshov VP, Slukvin II. Disturbances in immunity in children with recurrent respiratory diseases after Chernobyl accident. In: Chernobyl i zdorovje ludej. Kiev 1993: 8.
7. Chernyshov VP, Vykhovanetz YV, Slukvin II, Antipkin JG, Vasyuk AN, Strauss K. Immune system of Chernobyl children: developments in our understanding. In: One decade after Chernobyl: summing up the consequences of the accident. Austria, 8-12 April 1996: CN-63/135: 248-249.
8. Lukyanova EM, Chernyshov VP, Omelchenko LI et al. Die Behandlung immunsupprimierter Kinder nach dem Tschernobyl-Unfall mit Viscum album (Iscador°): klinische und immunologische Untersuchungen. Forsch Komplementärmed 1994; 1: 58-70.
9. Erkeller-Yuksel FM, Deneys V et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992; 120: 216-222.
10. Reichert T, De Bruyere M, Deneys V et al. Lymphocyte subsets reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991; 60: 190-208.
11. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64: 313-320.
12. Pross HF, Baines MG, Rubin P, Shragge P, Patterson S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1981; 1: 51-63.
13. Patterson-Delfield J, Lehrer PI. A simple microscopic method for identifying and quantitating phagocytic cells in vitro. J Immunol Methods 1977; 18: 377-379.
14. Baehner R, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968; 274: 971-976.
15. Ribéreau-Gayon G, Jung ML, Baudino S, Beck JP. Effects of mistletoe (Viscum album L.) extracts on cultered tumor cells. Experientia 1986; 42: 594-599.
16. Hajto T, Hostanska K, Gabius HJ. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador°) on the host defence system in vivo in rabbits and patients. Cancer Res 1989; 49: 4803-4808.
17. Kwaja T, Dias CB, Pentecost S. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 1986; 43 (suppl 1): 42-50.
18. Kiene H. Klinische Studien zur Misteltherapie der Krebserkrankung. Eine kritische Würdigung. Med. Diss. Witten/Herdecke 1989.
19. Rentea R, Lyon E, Hunter R. Biologic properties of Iscador®: a Viscum album preparation. Lab Invest 1981; 44: 43-48.